Analyst Activity – J P Morgan Chase & Co Reiterates Buy on Agios Pharmaceuticals (NASDAQ:AGIO)

Analyst Ratings For Agios Pharmaceuticals (NASDAQ:AGIO)

Today, J P Morgan Chase & Co reiterated its Buy rating on Agios Pharmaceuticals (NASDAQ:AGIO) with a price target of $76.00.

There are 1 hold rating, 11 buy ratings on the stock.

The current consensus rating on Agios Pharmaceuticals (NASDAQ:AGIO) is Buy (Score: 2.92) with a consensus target price of $75.20 per share, a potential 12.47% upside.

Some recent analyst ratings include

  • 9/18/2017-J P Morgan Chase & Co Reiterated Rating of Buy.
  • 9/14/2017-Royal Bank Of Canada initiated coverage with a Outperform rating.
  • 8/10/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
  • 8/8/2017-SunTrust Banks, Inc. Reiterated Rating of Buy .
  • 8/2/2017-Leerink Swann Upgrade from a “Market Perform ” rating to a ” Outperform” rating.

Recent Insider Trading Activity For Agios Pharmaceuticals (NASDAQ:AGIO)
Agios Pharmaceuticals (NASDAQ:AGIO) has insider ownership of 10.55% and institutional ownership of 94.40%.

  • On 9/14/2017 Lewis Clayton Jr. Cantley, Director, sold 4,000 with an average share price of $65.59 per share and the total transaction amounting to $262,360.00. View SEC Filing
  • On 9/13/2017 Lewis Clayton Jr. Cantley, Director, sold 1,000 with an average share price of $65.47 per share and the total transaction amounting to $65,470.00. View SEC Filing
  • On 9/11/2017 Scott Biller, Insider, sold 15,000 with an average share price of $65.00 per share and the total transaction amounting to $975,000.00. View SEC Filing
  • On 9/1/2017 David P Schenkein, CEO, sold 6,000 with an average share price of $62.20 per share and the total transaction amounting to $373,200.00. View SEC Filing
  • On 9/1/2017 Scott Biller, Insider, sold 2,146 with an average share price of $61.99 per share and the total transaction amounting to $133,030.54. View SEC Filing
  • On 8/23/2017 Lewis Clayton Jr. Cantley, Director, sold 4,000 with an average share price of $56.85 per share and the total transaction amounting to $227,400.00. View SEC Filing
  • On 8/2/2017 David P Schenkein, CEO, sold 27,000 with an average share price of $59.95 per share and the total transaction amounting to $1,618,650.00. View SEC Filing

Recent Trading Activity for Agios Pharmaceuticals (NASDAQ:AGIO)
Shares of Agios Pharmaceuticals closed the previous trading session at with shares trading hands.

An ad to help with our costs